nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—CYP3A5—Teniposide—lymphatic system cancer	0.133	0.177	CbGbCtD
Felodipine—CYP2C9—Teniposide—lymphatic system cancer	0.0893	0.119	CbGbCtD
Felodipine—CYP3A7—Vincristine—lymphatic system cancer	0.0854	0.114	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0854	0.114	CbGbCtD
Felodipine—CYP3A5—Vincristine—lymphatic system cancer	0.0641	0.0853	CbGbCtD
Felodipine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0606	0.0807	CbGbCtD
Felodipine—CYP3A4—Cytarabine—lymphatic system cancer	0.0527	0.0702	CbGbCtD
Felodipine—CYP3A4—Teniposide—lymphatic system cancer	0.0519	0.0691	CbGbCtD
Felodipine—ABCB1—Vincristine—lymphatic system cancer	0.0417	0.0555	CbGbCtD
Felodipine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0363	0.0484	CbGbCtD
Felodipine—ABCB1—Methotrexate—lymphatic system cancer	0.0253	0.0336	CbGbCtD
Felodipine—CYP3A4—Vincristine—lymphatic system cancer	0.025	0.0333	CbGbCtD
Felodipine—Allergic cutaneous angiitis—Methotrexate—lymphatic system cancer	0.00379	0.0152	CcSEcCtD
Felodipine—Tenderness—Bleomycin—lymphatic system cancer	0.00342	0.0137	CcSEcCtD
Felodipine—Visual disturbance—Fludarabine—lymphatic system cancer	0.00312	0.0125	CcSEcCtD
Felodipine—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00301	0.0121	CcSEcCtD
Felodipine—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00298	0.012	CcSEcCtD
Felodipine—Contusion—Mitoxantrone—lymphatic system cancer	0.00277	0.0111	CcSEcCtD
Felodipine—Loss of libido—Methotrexate—lymphatic system cancer	0.00261	0.0105	CcSEcCtD
Felodipine—Angina pectoris—Fludarabine—lymphatic system cancer	0.00249	0.00998	CcSEcCtD
Felodipine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00247	0.0099	CcSEcCtD
Felodipine—Leukocytoclastic vasculitis—Methotrexate—lymphatic system cancer	0.00246	0.00987	CcSEcCtD
Felodipine—Bronchitis—Fludarabine—lymphatic system cancer	0.00245	0.00986	CcSEcCtD
Felodipine—Dysuria—Fludarabine—lymphatic system cancer	0.00239	0.00958	CcSEcCtD
Felodipine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00237	0.00953	CcSEcCtD
Felodipine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00233	0.00935	CcSEcCtD
Felodipine—Urine output increased—Vincristine—lymphatic system cancer	0.00225	0.00902	CcSEcCtD
Felodipine—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00221	0.00887	CcSEcCtD
Felodipine—Flushing—Teniposide—lymphatic system cancer	0.00216	0.00866	CcSEcCtD
Felodipine—Epistaxis—Fludarabine—lymphatic system cancer	0.00215	0.00862	CcSEcCtD
Felodipine—Swelling—Carmustine—lymphatic system cancer	0.00214	0.0086	CcSEcCtD
Felodipine—Sinusitis—Fludarabine—lymphatic system cancer	0.00213	0.00857	CcSEcCtD
Felodipine—Arrhythmia—Teniposide—lymphatic system cancer	0.00208	0.00834	CcSEcCtD
Felodipine—Polyuria—Vincristine—lymphatic system cancer	0.00205	0.00825	CcSEcCtD
Felodipine—Pharyngitis—Fludarabine—lymphatic system cancer	0.00203	0.00814	CcSEcCtD
Felodipine—Swelling—Mitoxantrone—lymphatic system cancer	0.00199	0.008	CcSEcCtD
Felodipine—Visual impairment—Fludarabine—lymphatic system cancer	0.00197	0.00791	CcSEcCtD
Felodipine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00193	0.00776	CcSEcCtD
Felodipine—Anaemia—Teniposide—lymphatic system cancer	0.00187	0.00751	CcSEcCtD
Felodipine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00182	0.00733	CcSEcCtD
Felodipine—Face oedema—Carmustine—lymphatic system cancer	0.00182	0.00733	CcSEcCtD
Felodipine—Pain in extremity—Vincristine—lymphatic system cancer	0.0018	0.00724	CcSEcCtD
Felodipine—Chest pain—Teniposide—lymphatic system cancer	0.00172	0.00692	CcSEcCtD
Felodipine—Confusional state—Teniposide—lymphatic system cancer	0.00166	0.00669	CcSEcCtD
Felodipine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00165	0.00663	CcSEcCtD
Felodipine—Anaemia—Fludarabine—lymphatic system cancer	0.00164	0.0066	CcSEcCtD
Felodipine—Tachycardia—Teniposide—lymphatic system cancer	0.00161	0.00647	CcSEcCtD
Felodipine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00158	0.00636	CcSEcCtD
Felodipine—Cough—Fludarabine—lymphatic system cancer	0.00155	0.00623	CcSEcCtD
Felodipine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00153	0.00615	CcSEcCtD
Felodipine—Myalgia—Fludarabine—lymphatic system cancer	0.00151	0.00608	CcSEcCtD
Felodipine—Arthralgia—Fludarabine—lymphatic system cancer	0.00151	0.00608	CcSEcCtD
Felodipine—Dyspnoea—Teniposide—lymphatic system cancer	0.00147	0.00591	CcSEcCtD
Felodipine—Confusional state—Fludarabine—lymphatic system cancer	0.00146	0.00588	CcSEcCtD
Felodipine—Dysuria—Vincristine—lymphatic system cancer	0.00146	0.00586	CcSEcCtD
Felodipine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00144	0.00577	CcSEcCtD
Felodipine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00142	0.00572	CcSEcCtD
Felodipine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00142	0.00572	CcSEcCtD
Felodipine—Rash—Mechlorethamine—lymphatic system cancer	0.00141	0.00567	CcSEcCtD
Felodipine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00141	0.00567	CcSEcCtD
Felodipine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00141	0.00567	CcSEcCtD
Felodipine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.0014	0.00562	CcSEcCtD
Felodipine—Flushing—Bleomycin—lymphatic system cancer	0.00139	0.00558	CcSEcCtD
Felodipine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00136	0.00546	CcSEcCtD
Felodipine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00135	0.00542	CcSEcCtD
Felodipine—Nausea—Mechlorethamine—lymphatic system cancer	0.00133	0.00534	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00132	0.00531	CcSEcCtD
Felodipine—Urticaria—Teniposide—lymphatic system cancer	0.00131	0.00527	CcSEcCtD
Felodipine—Abdominal pain—Teniposide—lymphatic system cancer	0.00131	0.00524	CcSEcCtD
Felodipine—Body temperature increased—Teniposide—lymphatic system cancer	0.00131	0.00524	CcSEcCtD
Felodipine—Erythema—Bleomycin—lymphatic system cancer	0.0013	0.00524	CcSEcCtD
Felodipine—Paraesthesia—Fludarabine—lymphatic system cancer	0.0013	0.00523	CcSEcCtD
Felodipine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00129	0.0052	CcSEcCtD
Felodipine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00129	0.00517	CcSEcCtD
Felodipine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00128	0.00513	CcSEcCtD
Felodipine—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00127	0.0051	CcSEcCtD
Felodipine—Visual impairment—Carmustine—lymphatic system cancer	0.00126	0.00506	CcSEcCtD
Felodipine—Fatigue—Fludarabine—lymphatic system cancer	0.00125	0.00502	CcSEcCtD
Felodipine—Constipation—Fludarabine—lymphatic system cancer	0.00124	0.00498	CcSEcCtD
Felodipine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00124	0.00497	CcSEcCtD
Felodipine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00122	0.00489	CcSEcCtD
Felodipine—Flushing—Carmustine—lymphatic system cancer	0.00121	0.00487	CcSEcCtD
Felodipine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00121	0.00484	CcSEcCtD
Felodipine—Anaemia—Bleomycin—lymphatic system cancer	0.0012	0.00484	CcSEcCtD
Felodipine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0012	0.0048	CcSEcCtD
Felodipine—Asthenia—Teniposide—lymphatic system cancer	0.00118	0.00476	CcSEcCtD
Felodipine—Pruritus—Teniposide—lymphatic system cancer	0.00117	0.00469	CcSEcCtD
Felodipine—Arrhythmia—Carmustine—lymphatic system cancer	0.00117	0.00469	CcSEcCtD
Felodipine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00115	0.00461	CcSEcCtD
Felodipine—Erythema—Carmustine—lymphatic system cancer	0.00114	0.00457	CcSEcCtD
Felodipine—Cough—Bleomycin—lymphatic system cancer	0.00114	0.00457	CcSEcCtD
Felodipine—Diarrhoea—Teniposide—lymphatic system cancer	0.00113	0.00454	CcSEcCtD
Felodipine—Chest pain—Bleomycin—lymphatic system cancer	0.00111	0.00446	CcSEcCtD
Felodipine—Myalgia—Bleomycin—lymphatic system cancer	0.00111	0.00446	CcSEcCtD
Felodipine—Back pain—Carmustine—lymphatic system cancer	0.0011	0.00442	CcSEcCtD
Felodipine—Urine output increased—Methotrexate—lymphatic system cancer	0.00109	0.00438	CcSEcCtD
Felodipine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00109	0.00436	CcSEcCtD
Felodipine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00108	0.00433	CcSEcCtD
Felodipine—Confusional state—Bleomycin—lymphatic system cancer	0.00107	0.00431	CcSEcCtD
Felodipine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00107	0.00429	CcSEcCtD
Felodipine—Tremor—Carmustine—lymphatic system cancer	0.00107	0.00428	CcSEcCtD
Felodipine—Erythema—Mitoxantrone—lymphatic system cancer	0.00106	0.00425	CcSEcCtD
Felodipine—Anaemia—Carmustine—lymphatic system cancer	0.00105	0.00422	CcSEcCtD
Felodipine—Back pain—Vincristine—lymphatic system cancer	0.00105	0.00422	CcSEcCtD
Felodipine—Vomiting—Teniposide—lymphatic system cancer	0.00105	0.00422	CcSEcCtD
Felodipine—Asthenia—Fludarabine—lymphatic system cancer	0.00104	0.00418	CcSEcCtD
Felodipine—Rash—Teniposide—lymphatic system cancer	0.00104	0.00418	CcSEcCtD
Felodipine—Dermatitis—Teniposide—lymphatic system cancer	0.00104	0.00418	CcSEcCtD
Felodipine—Headache—Teniposide—lymphatic system cancer	0.00103	0.00415	CcSEcCtD
Felodipine—Pruritus—Fludarabine—lymphatic system cancer	0.00103	0.00412	CcSEcCtD
Felodipine—Back pain—Mitoxantrone—lymphatic system cancer	0.00102	0.00411	CcSEcCtD
Felodipine—Anaemia—Vincristine—lymphatic system cancer	0.001	0.00403	CcSEcCtD
Felodipine—Polyuria—Methotrexate—lymphatic system cancer	0.000997	0.004	CcSEcCtD
Felodipine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000993	0.00399	CcSEcCtD
Felodipine—Nausea—Teniposide—lymphatic system cancer	0.000981	0.00394	CcSEcCtD
Felodipine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000978	0.00393	CcSEcCtD
Felodipine—Vertigo—Vincristine—lymphatic system cancer	0.000976	0.00392	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000969	0.00389	CcSEcCtD
Felodipine—Myalgia—Carmustine—lymphatic system cancer	0.000969	0.00389	CcSEcCtD
Felodipine—Chest pain—Carmustine—lymphatic system cancer	0.000969	0.00389	CcSEcCtD
Felodipine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000955	0.00384	CcSEcCtD
Felodipine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000949	0.00381	CcSEcCtD
Felodipine—Confusional state—Carmustine—lymphatic system cancer	0.000936	0.00376	CcSEcCtD
Felodipine—Myalgia—Vincristine—lymphatic system cancer	0.000925	0.00371	CcSEcCtD
Felodipine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000924	0.00371	CcSEcCtD
Felodipine—Cough—Mitoxantrone—lymphatic system cancer	0.000923	0.00371	CcSEcCtD
Felodipine—Vomiting—Fludarabine—lymphatic system cancer	0.000923	0.00371	CcSEcCtD
Felodipine—Rash—Fludarabine—lymphatic system cancer	0.000915	0.00367	CcSEcCtD
Felodipine—Dermatitis—Fludarabine—lymphatic system cancer	0.000914	0.00367	CcSEcCtD
Felodipine—Headache—Fludarabine—lymphatic system cancer	0.000909	0.00365	CcSEcCtD
Felodipine—Tachycardia—Carmustine—lymphatic system cancer	0.000906	0.00364	CcSEcCtD
Felodipine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000901	0.00362	CcSEcCtD
Felodipine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000901	0.00362	CcSEcCtD
Felodipine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000901	0.00362	CcSEcCtD
Felodipine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000893	0.00359	CcSEcCtD
Felodipine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000877	0.00352	CcSEcCtD
Felodipine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000871	0.0035	CcSEcCtD
Felodipine—Nausea—Fludarabine—lymphatic system cancer	0.000862	0.00346	CcSEcCtD
Felodipine—Shock—Mitoxantrone—lymphatic system cancer	0.000849	0.00341	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000846	0.0034	CcSEcCtD
Felodipine—Urticaria—Bleomycin—lymphatic system cancer	0.000845	0.00339	CcSEcCtD
Felodipine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000843	0.00338	CcSEcCtD
Felodipine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000841	0.00338	CcSEcCtD
Felodipine—Insomnia—Carmustine—lymphatic system cancer	0.00084	0.00337	CcSEcCtD
Felodipine—Irritability—Methotrexate—lymphatic system cancer	0.000835	0.00336	CcSEcCtD
Felodipine—Paraesthesia—Carmustine—lymphatic system cancer	0.000834	0.00335	CcSEcCtD
Felodipine—Dyspnoea—Carmustine—lymphatic system cancer	0.000828	0.00333	CcSEcCtD
Felodipine—Somnolence—Carmustine—lymphatic system cancer	0.000826	0.00332	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000808	0.00324	CcSEcCtD
Felodipine—Insomnia—Vincristine—lymphatic system cancer	0.000802	0.00322	CcSEcCtD
Felodipine—Paraesthesia—Vincristine—lymphatic system cancer	0.000796	0.0032	CcSEcCtD
Felodipine—Constipation—Carmustine—lymphatic system cancer	0.000794	0.00319	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000787	0.00316	CcSEcCtD
Felodipine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000784	0.00315	CcSEcCtD
Felodipine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000775	0.00311	CcSEcCtD
Felodipine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00077	0.00309	CcSEcCtD
Felodipine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000768	0.00308	CcSEcCtD
Felodipine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000765	0.00307	CcSEcCtD
Felodipine—Fatigue—Vincristine—lymphatic system cancer	0.000764	0.00307	CcSEcCtD
Felodipine—Asthenia—Bleomycin—lymphatic system cancer	0.000763	0.00307	CcSEcCtD
Felodipine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00076	0.00305	CcSEcCtD
Felodipine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000759	0.00305	CcSEcCtD
Felodipine—Constipation—Vincristine—lymphatic system cancer	0.000758	0.00304	CcSEcCtD
Felodipine—Pruritus—Bleomycin—lymphatic system cancer	0.000753	0.00302	CcSEcCtD
Felodipine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000744	0.00299	CcSEcCtD
Felodipine—Constipation—Mitoxantrone—lymphatic system cancer	0.000738	0.00297	CcSEcCtD
Felodipine—Body temperature increased—Carmustine—lymphatic system cancer	0.000734	0.00295	CcSEcCtD
Felodipine—Abdominal pain—Carmustine—lymphatic system cancer	0.000734	0.00295	CcSEcCtD
Felodipine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000725	0.00291	CcSEcCtD
Felodipine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000725	0.00291	CcSEcCtD
Felodipine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000711	0.00286	CcSEcCtD
Felodipine—Dysuria—Methotrexate—lymphatic system cancer	0.000707	0.00284	CcSEcCtD
Felodipine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000706	0.00284	CcSEcCtD
Felodipine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000703	0.00282	CcSEcCtD
Felodipine—Abdominal pain—Vincristine—lymphatic system cancer	0.000701	0.00281	CcSEcCtD
Felodipine—Body temperature increased—Vincristine—lymphatic system cancer	0.000701	0.00281	CcSEcCtD
Felodipine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000697	0.0028	CcSEcCtD
Felodipine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00069	0.00277	CcSEcCtD
Felodipine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000686	0.00275	CcSEcCtD
Felodipine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000684	0.00275	CcSEcCtD
Felodipine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000682	0.00274	CcSEcCtD
Felodipine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000682	0.00274	CcSEcCtD
Felodipine—Vomiting—Bleomycin—lymphatic system cancer	0.000676	0.00272	CcSEcCtD
Felodipine—Rash—Bleomycin—lymphatic system cancer	0.000671	0.00269	CcSEcCtD
Felodipine—Dermatitis—Bleomycin—lymphatic system cancer	0.00067	0.00269	CcSEcCtD
Felodipine—Asthenia—Carmustine—lymphatic system cancer	0.000666	0.00268	CcSEcCtD
Felodipine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000653	0.00262	CcSEcCtD
Felodipine—Epistaxis—Methotrexate—lymphatic system cancer	0.000636	0.00256	CcSEcCtD
Felodipine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000636	0.00255	CcSEcCtD
Felodipine—Asthenia—Vincristine—lymphatic system cancer	0.000636	0.00255	CcSEcCtD
Felodipine—Diarrhoea—Carmustine—lymphatic system cancer	0.000635	0.00255	CcSEcCtD
Felodipine—Nausea—Bleomycin—lymphatic system cancer	0.000632	0.00254	CcSEcCtD
Felodipine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000619	0.00249	CcSEcCtD
Felodipine—Dizziness—Carmustine—lymphatic system cancer	0.000614	0.00247	CcSEcCtD
Felodipine—Diarrhoea—Vincristine—lymphatic system cancer	0.000607	0.00244	CcSEcCtD
Felodipine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000601	0.00241	CcSEcCtD
Felodipine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000591	0.00237	CcSEcCtD
Felodipine—Vomiting—Carmustine—lymphatic system cancer	0.00059	0.00237	CcSEcCtD
Felodipine—Dizziness—Vincristine—lymphatic system cancer	0.000586	0.00235	CcSEcCtD
Felodipine—Rash—Carmustine—lymphatic system cancer	0.000586	0.00235	CcSEcCtD
Felodipine—Dermatitis—Carmustine—lymphatic system cancer	0.000585	0.00235	CcSEcCtD
Felodipine—Visual impairment—Methotrexate—lymphatic system cancer	0.000583	0.00234	CcSEcCtD
Felodipine—Headache—Carmustine—lymphatic system cancer	0.000582	0.00234	CcSEcCtD
Felodipine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000572	0.0023	CcSEcCtD
Felodipine—Vomiting—Vincristine—lymphatic system cancer	0.000564	0.00226	CcSEcCtD
Felodipine—Rash—Vincristine—lymphatic system cancer	0.000559	0.00225	CcSEcCtD
Felodipine—Dermatitis—Vincristine—lymphatic system cancer	0.000558	0.00224	CcSEcCtD
Felodipine—Headache—Vincristine—lymphatic system cancer	0.000555	0.00223	CcSEcCtD
Felodipine—Nausea—Carmustine—lymphatic system cancer	0.000552	0.00222	CcSEcCtD
Felodipine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000549	0.0022	CcSEcCtD
Felodipine—Rash—Mitoxantrone—lymphatic system cancer	0.000544	0.00219	CcSEcCtD
Felodipine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000544	0.00218	CcSEcCtD
Felodipine—Headache—Mitoxantrone—lymphatic system cancer	0.000541	0.00217	CcSEcCtD
Felodipine—Erythema—Methotrexate—lymphatic system cancer	0.000527	0.00212	CcSEcCtD
Felodipine—Nausea—Vincristine—lymphatic system cancer	0.000527	0.00212	CcSEcCtD
Felodipine—Nausea—Mitoxantrone—lymphatic system cancer	0.000513	0.00206	CcSEcCtD
Felodipine—Back pain—Methotrexate—lymphatic system cancer	0.00051	0.00205	CcSEcCtD
Felodipine—Anaemia—Methotrexate—lymphatic system cancer	0.000487	0.00196	CcSEcCtD
Felodipine—Vertigo—Methotrexate—lymphatic system cancer	0.000474	0.0019	CcSEcCtD
Felodipine—Cough—Methotrexate—lymphatic system cancer	0.00046	0.00185	CcSEcCtD
Felodipine—Chest pain—Methotrexate—lymphatic system cancer	0.000449	0.0018	CcSEcCtD
Felodipine—Myalgia—Methotrexate—lymphatic system cancer	0.000449	0.0018	CcSEcCtD
Felodipine—Arthralgia—Methotrexate—lymphatic system cancer	0.000449	0.0018	CcSEcCtD
Felodipine—Confusional state—Methotrexate—lymphatic system cancer	0.000434	0.00174	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000392	0.00157	CcSEcCtD
Felodipine—Insomnia—Methotrexate—lymphatic system cancer	0.000389	0.00156	CcSEcCtD
Felodipine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000386	0.00155	CcSEcCtD
Felodipine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000383	0.00154	CcSEcCtD
Felodipine—Somnolence—Methotrexate—lymphatic system cancer	0.000382	0.00154	CcSEcCtD
Felodipine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000379	0.00152	CcSEcCtD
Felodipine—Fatigue—Methotrexate—lymphatic system cancer	0.000371	0.00149	CcSEcCtD
Felodipine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000354	0.00142	CcSEcCtD
Felodipine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000352	0.00141	CcSEcCtD
Felodipine—Urticaria—Methotrexate—lymphatic system cancer	0.000342	0.00137	CcSEcCtD
Felodipine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00034	0.00137	CcSEcCtD
Felodipine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00034	0.00137	CcSEcCtD
Felodipine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000317	0.00127	CcSEcCtD
Felodipine—Asthenia—Methotrexate—lymphatic system cancer	0.000309	0.00124	CcSEcCtD
Felodipine—Pruritus—Methotrexate—lymphatic system cancer	0.000304	0.00122	CcSEcCtD
Felodipine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000294	0.00118	CcSEcCtD
Felodipine—Dizziness—Methotrexate—lymphatic system cancer	0.000284	0.00114	CcSEcCtD
Felodipine—Vomiting—Methotrexate—lymphatic system cancer	0.000273	0.0011	CcSEcCtD
Felodipine—Rash—Methotrexate—lymphatic system cancer	0.000271	0.00109	CcSEcCtD
Felodipine—Dermatitis—Methotrexate—lymphatic system cancer	0.000271	0.00109	CcSEcCtD
Felodipine—Headache—Methotrexate—lymphatic system cancer	0.000269	0.00108	CcSEcCtD
Felodipine—Nausea—Methotrexate—lymphatic system cancer	0.000256	0.00103	CcSEcCtD
